These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 34274962)

  • 1. Primary Hypogammaglobulinaemia with Inflammatory Bowel Disease-Like Features: An ECCO CONFER Multicentre Case Series.
    Albshesh A; Eder P; Ribaldone DG; Oldenburg B; de Boer NK; Mantzaris GJ; Savarino EV; Dragoni G; Weisshof R; Truyens M; Festa S; Maillard MH; Capirchio L; Filip R; Theodoraki E; Kopylov U
    J Crohns Colitis; 2022 Jan; 16(1):91-97. PubMed ID: 34274962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Idiopathic Thrombocytopaenic Purpura associated with Inflammatory Bowel Disease: a multicentre ECCO CONFER case series.
    Mahajna H; Verstockt B; Bergemalm D; Castiglione F; Rodríguez-Moranta F; Savarino E; Hoentjen F; Bessissow T; Pokryszka J; Cremer A; Eder P; Truyens M; Yerushalmy-Feler A; García MJ; Kopylov U
    J Crohns Colitis; 2023 May; 17(5):722-727. PubMed ID: 36455965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hereditary Colorectal Cancer Syndromes and Inflammatory Bowel Diseases: an ECCO CONFER Multicentre Case Series.
    Barberio B; Savarino E; Verstockt B; Fumery M; Pugliese D; Bertani L; Buda A; Dragoni G; Goren I; Laish I; Spinelli A; Teich N; Truyens M; Ellul P
    J Crohns Colitis; 2022 Dec; 16(12):1845-1852. PubMed ID: 35771951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis and Outcome of Extranodal Primary Intestinal Lymphoma in Inflammatory Bowel Disease: An ECCO CONFER Case Series.
    Phillips F; Verstockt B; Ribaldone DG; Guerra I; Teich N; Katsanos K; Filip R; Molner T; Karmiris K;
    J Crohns Colitis; 2022 Mar; 16(3):500-505. PubMed ID: 34508639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastroenteropancreatic Neuroendocrine Neoplasms in Patients with Inflammatory Bowel Disease: An ECCO CONFER Multicentre Case Series.
    Festa S; Zerboni G; Derikx LAAP; Ribaldone DG; Dragoni G; Buskens C; van Dijkum EN; Pugliese D; Panzuto F; Krela-Kaźmierczak I; Mintz HR; Shitrit AB; Chaparro M; Gisbert JP; Kopylov U; Teich N; Vainer E; Nagtegaal I; Hoentjen F; Garcia MJ; Filip R; Foteinogiannopoulou K; Koutroubakis IE; Argollo M; van Wanrooij RLJ; Laja H; Lobaton T; Truyens M; Molnar T; Savarino E; Aratari A; Papi C; Goren I
    J Crohns Colitis; 2022 Jul; 16(6):940-945. PubMed ID: 34864927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory Cutaneous Lesions in Inflammatory Bowel Disease Treated With Vedolizumab or Ustekinumab: An ECCO CONFER Multicentre Case Series.
    Phillips FM; Verstockt B; Sebastian S; Ribaldone D; Vavricka S; Katsanos K; Slattery E; de Suray N; Flores C; Fries W; Vincenzi F; Capoferro E; Bachmann O; Kopylov U
    J Crohns Colitis; 2020 Oct; 14(10):1488-1493. PubMed ID: 32318735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoimmune Pancreatitis in Patients with Inflammatory Bowel Disease: A Real-World Multicentre Collaborative ECCO CONFER Study.
    Eder P; Verstock B; Culver E; Dragoni G; Kredel LI; Wypych J; de Paredes AGG; Kaniewska M; Leibovitzh H; Lobaton T; Truyens M; Oracz G; Ribaldone DG; Starzyńska T; Badaoui A; Rahier JF; Bezzio C; Bossuyt P; Falloon K; Pugliese D; Frakes Vozzo C; Jess T; Larsen L; Olesen SS; Pal P; Chaparro M; Dror D; Ellul P; Gromny I; Janiak M; Maciejewska K; Peleg N; Bar-Gil Shitrit A; Szwed Ł; Talar-Wojnarowska R; Snir Y; Weisshof R; Zittan E; Miechowicz I; Goren I
    J Crohns Colitis; 2023 Nov; 17(11):1791-1799. PubMed ID: 37283545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cogan's Syndrome in Patients With Inflammatory Bowel Disease--A Case Series.
    Vavricka SR; Greuter T; Scharl M; Mantzaris G; Shitrit AB; Filip R; Karmiris K; Thoeringer CK; Boldys H; Wewer AV; Yanai H; Flores C; Schmidt C; Kariv R; Rogler G; Rahier JF;
    J Crohns Colitis; 2015 Oct; 9(10):886-90. PubMed ID: 26188351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrovascular events in inflammatory bowel disease patients treated with anti-tumour necrosis factor alpha agents.
    Karmiris K; Bossuyt P; Sorrentino D; Moreels T; Scarcelli A; Legido J; Dotan I; Naismith GD; Jussila A; Preiss JC; Kruis W; Li AC; Bouguen G; Yanai H; Steinwurz F; Katsanos KH; Subramaniam K; Tarabar D; Zaganas IV; Ben-Horin S;
    J Crohns Colitis; 2015 May; 9(5):382-9. PubMed ID: 25740813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-hepatic Solid Organ Transplant in Patients with Inflammatory Bowel Disease: An ECCO CONFER Multicentre Case Series.
    Ribaldone DG; Vieujean S; Julsgaard M; Armandi A; Zingone F; Savarino E; Cañete F; Aratari A; Imperatore N; Ramos L; Plaza R; Pugliese D; Barberio B; Drobne D; Chaparro M
    J Crohns Colitis; 2023 Jul; 17(7):1097-1102. PubMed ID: 36815684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. East-West gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort.
    Burisch J; Pedersen N; Čuković-Čavka S; Brinar M; Kaimakliotis I; Duricova D; Shonová O; Vind I; Avnstrøm S; Thorsgaard N; Andersen V; Krabbe S; Dahlerup JF; Salupere R; Nielsen KR; Olsen J; Manninen P; Collin P; Tsianos EV; Katsanos KH; Ladefoged K; Lakatos L; Björnsson E; Ragnarsson G; Bailey Y; Odes S; Schwartz D; Martinato M; Lupinacci G; Milla M; De Padova A; D'Incà R; Beltrami M; Kupcinskas L; Kiudelis G; Turcan S; Tighineanu O; Mihu I; Magro F; Barros LF; Goldis A; Lazar D; Belousova E; Nikulina I; Hernandez V; Martinez-Ares D; Almer S; Zhulina Y; Halfvarson J; Arebi N; Sebastian S; Lakatos PL; Langholz E; Munkholm P;
    Gut; 2014 Apr; 63(4):588-97. PubMed ID: 23604131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysplasia and cancer in inflammatory bowel disease 10 years after diagnosis: results of a population-based European collaborative follow-up study.
    Katsanos KH; Vermeire S; Christodoulou DK; Riis L; Wolters F; Odes S; Freitas J; Hoie O; Beltrami M; Fornaciari G; Clofent J; Bodini P; Vatn M; Nunes PB; Moum B; Munkholm P; Limonard C; Stockbrugger R; Rutgeerts P; Tsianos EV;
    Digestion; 2007; 75(2-3):113-21. PubMed ID: 17598963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of inflammatory bowel disease during anti-TNF-α therapy for inflammatory rheumatic disease: a nationwide series.
    Toussirot É; Houvenagel É; Goëb V; Fouache D; Martin A; Le Dantec P; Dernis E; Wendling D; Ansemant T; Berthelot JM; Bader-Meunier B; Kantelip B;
    Joint Bone Spine; 2012 Oct; 79(5):457-63. PubMed ID: 22088934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of Combination Antibiotic Therapy for Refractory Pediatric Inflammatory Bowel Disease.
    Breton J; Kastl A; Hoffmann N; Rogers R; Grossman AB; Mamula P; Kelsen JR; Baldassano RN; Albenberg L
    Inflamm Bowel Dis; 2019 Aug; 25(9):1586-1593. PubMed ID: 30715364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and laboratory features of seventy-eight UK patients with Good's syndrome (thymoma and hypogammaglobulinaemia).
    Zaman M; Huissoon A; Buckland M; Patel S; Alachkar H; Edgar JD; Thomas M; Arumugakani G; Baxendale H; Burns S; Williams AP; Jolles S; Herriot R; Sargur RB; Arkwright PD
    Clin Exp Immunol; 2019 Jan; 195(1):132-138. PubMed ID: 30216434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Low Immunoglobulin G Levels on Disease Outcomes in Patients with Inflammatory Bowel Diseases.
    Horton N; Wu X; Philpott J; Garber A; Achkar JP; Brzezinski A; Lashner BA; Shen B
    Dig Dis Sci; 2016 Nov; 61(11):3270-3277. PubMed ID: 27619393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment Steps, Surgery, and Hospitalization Rates During the First Year of Follow-up in Patients with Inflammatory Bowel Diseases from the 2011 ECCO-Epicom Inception Cohort.
    Vegh Z; Burisch J; Pedersen N; Kaimakliotis I; Duricova D; Bortlik M; Vinding KK; Avnstrøm S; Olsen J; Nielsen KR; Katsanos KH; Tsianos EV; Lakatos L; Schwartz D; Odes S; D'Incà R; Beltrami M; Kiudelis G; Kupcinskap L; Jucov A; Turcan S; Barros LF; Magro F; Lazar D; Goldis A; de Castro L; Hernandez V; Niewiadomski O; Bell S; Langholz E; Munkholm P; Lakatos PL;
    J Crohns Colitis; 2015 Sep; 9(9):747-53. PubMed ID: 26055976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Orofacial Granulomatosis Associated with Crohn's Disease: a Multicentre Case Series.
    Phillips F; Verstockt B; Sladek M; de Boer N; Katsanos K; Karmiris K; Albshesh A; Erikson C; Bergemalm D; Molnar T; Ellul P
    J Crohns Colitis; 2022 Mar; 16(3):430-435. PubMed ID: 34498037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Risk of Later Diagnosis of Inflammatory Bowel Disease in Patients With Dermatological Disorders Associated With Inflammatory Bowel Disease.
    King D; Chandan JS; Thomas T; Nirantharakumar K; Reulen RC; Adderley NJ; Trudgill N
    Inflamm Bowel Dis; 2021 Oct; 27(11):1731-1739. PubMed ID: 34669933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.